Michael E. Tarnoff's most recent trade in Angiodynamic Inc was a trade of 11,887 Common Stock done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 11,887 | 95,265 (0%) | 0% | 0 | Common Stock | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,250 | 26,250 | - | - | Common Stock | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 48,464 | - | - | Common Stock | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,063 | 19,063 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 17,675 | 83,378 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 65,703 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,060 | 28,121 (0%) | 0% | 0 | Common Stock |